By use of standard cuprate methodology, a series of 18-cycloalkyl analogues of enisoprost was prepared in an effort to impede omega chain metabolism and prolong duration of gastric antisecretory activity. An initial product of omega chain oxidation, the C-20 hydroxy analogue, was also synthesized for pharmacological comparison. The cyclopropyl, cyclobutyl, and cyclopentyl analogues were approximately one-fourth as potent as enisoprost in inhibiting gastric acid secretion, while the cyclohexyl and cycloheptyl analogues showed very weak activity, and the 20-hydroxy compound was inactive at a dose 100 times the ED50 of enisoprost. The cyclobutyl compound had a longer duration of antisecretory action than enisoprost and the other cycloalkyl analogues. The cycloalkyl analogues unexpectedly possessed low diarrheogenic activity in rats.
Transferhydrogenation reactions are of great interest to reduce diverse molecules under mild reaction conditions. To date, this type of reaction has only been successfully applied to alkenes, alkynes and polarized unsaturated compounds such as ketones, imines, pyridines, etc. The reduction of benzene derivatives by transferhydrogenation has never been described, which is likely due to the high energy
COMPOUNDS HAVING A POTENTIATING EFFECT ON THE ACTIVITY OF ETHIONAMIDE AND USES THEREOF
申请人:Deprez Benôit
公开号:US20110136823A1
公开(公告)日:2011-06-09
The present invention relates to the use of compounds with a potentiating effect on the activity of antibiotics that are activatable via the EthA enzymatic pathway, for the preparation of a medicament for preventing and/or treating mycobacterial infections such as tuberculosis and leprosy, to pharmaceutical compositions comprising them in combination with an antibiotic that is activatable via the EthA pathway, to compounds having a potentiating effect on the activity of antibiotics that are activatable via the EthA enzymatic pathway, to pharmaceutical compositions comprising them and to their use as medicaments, especially medicaments for preventing and/or treating mycobacterial infections such as tuberculosis and leprosy.
Iridium-Catalyzed Alkene-Selective Transfer Hydrogenation with 1,4-Dioxane as Hydrogen Donor
作者:Deliang Zhang、Tomohiro Iwai、Masaya Sawamura
DOI:10.1021/acs.orglett.9b01989
日期:2019.8.2
using 1,4-dioxane as a hydrogen donor is described. The use of 1,2-bis(dicyclohexylphosphino)ethane (DCyPE), featuring bulky and highly electron-donating properties, led to high catalytic activity. A polystyrene-cross-linking bisphosphine PS-DPPBz produced a reusable heterogeneous catalyst. These homogeneous and heterogeneous protocols achieved chemoselective transfer hydrogenation of alkenes over
Rhodium–nickel bimetallic nanocatalysts: high performance of room-temperature hydrogenation
作者:Haohong Duan、Dingsheng Wang、Yuan Kou、Yadong Li
DOI:10.1039/c2cc37668g
日期:——
Rhodiumânickel bimetallic nanocrystals were fabricated with high activity in hydrogenation of olefins, nitroarenes and arenes at room temperature, indicating that bimetallic nanocrystals of noble and non-noble metals represent a novel kind of nanocatalyst.
Bimetallic Nanoparticles in Supported Ionic Liquid Phases as Multifunctional Catalysts for the Selective Hydrodeoxygenation of Aromatic Substrates
作者:Lisa Offner-Marko、Alexis Bordet、Gilles Moos、Simon Tricard、Simon Rengshausen、Bruno Chaudret、Kylie L. Luska、Walter Leitner
DOI:10.1002/anie.201806638
日期:2018.9.24
Bimetallic iron–ruthenium nanoparticles embedded in an acidic supported ionic liquidphase (FeRu@SILP+IL‐SO3H) act as multifunctional catalysts for the selective hydrodeoxygenation of carbonyl groups in aromatic substrates. The catalyst material is assembled systematically from molecular components to combine the acid and metal sites that allow hydrogenolysis of the C=O bonds without hydrogenation